Insider · CIK 0001971187
Adam Taich
cfoofficer
Files at TXG (10x Genomics, Inc.). First filing May 27, 2025, latest Sep 11, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 3
$0 bought, $3.3M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
TXG: 10x Genomics, Inc.
TXGOct 9, 2026 · close 80.65
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 47Moderate | 10x Genomics, Inc. | $3.0M 46,388 shares | -13% | +493% from low0% from high | |
| 51Moderate | 10x Genomics, Inc. | $308k 22,315 shares | -7% | +100% from low-39% from high | |
| 43Moderate | 10x Genomics, Inc. | $34k 4,044 shares | -1% | +20% from low-64% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 9, 2026 | TXG 10x Genomics, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -1,206 | $63.68 | $77k | 361,526 | 31 d ago |
| Sep 9, 2026 | TXG 10x Genomics, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -31,428 | $64.31 | $2.0M | 330,098 | 31 d ago |
| Sep 9, 2026 | TXG 10x Genomics, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -13,754 | $65.26 | $898k | 316,344 | 31 d ago |
| Aug 22, 2025 | TXG 10x Genomics, Inc. | SOpen-market sale Class A Common Stock | -22,315 | $13.79 | $308k | 309,273 | Aug 26, 2025 |
| May 22, 2025 | TXG 10x Genomics, Inc. | SOpen-market sale Class A Common Stock | -4,044 | $8.30 | $34k | 331,588 | May 27, 2025 |
| Oct 23, 2024 | TXG 10x Genomics, Inc. | AGrant or award Class A Common Stock | +201,704 | $0.00 | $0 | 201,704 | Mar 19, 2025 |
| Mar 17, 2025 | TXG 10x Genomics, Inc. | AGrant or award Class A Common Stock | +133,928 | $0.00 | $0 | 335,632 | Mar 19, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.